Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets
Company Announcements

Zivo Bioscience Inc Faces Nasdaq Delisting and Shifts to OTC Markets

Zivo Bioscience Inc (ZIVO) has released an update.

Nasdaq is set to delist Zivo Bioscience, Inc.’s common stock and warrants due to noncompliance with its listing rules, moving from a suspension initiated on November 27, 2023. Since the suspension, Zivo’s common stock and warrants have been trading over the counter on OTC Markets’ Pink Sheets, and more recently, the common stock on the OTCQB market tier. This transition allows continued trading under the symbols ZIVO and ZIVOW, respectively.

For further insights into ZIVO stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskZivo Bioscience Strengthens Board with New Director Appointment
TheFlyZivo and animal health firm launch study targeting coccidiosis treatment
TipRanks Auto-Generated NewsdeskZivo Bioscience Enhances Equity Incentive Plans for Leadership
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!